Back to search

Article

Targeting endometrial cancer stem cell activity with metformin is inhibited by patient-derived adipocyte-secreted factors

2019-02-28

Abstract excerpt

<h4>Translational relevance</h4> Endometrial cancer stem cells are reported to drive metastasis and disease relapse and are resistant to commonly used chemotherapeutic drugs. Here, we characterise ALDH high and CD133 +ve endometrial cancer stem cells with differing levels of cancer stem cell activity and stem cell and epithelial-mesenchymal transition (EMT) gene expression. Their proportions and activity are re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5674e81c-ea22-518d-8df4-197bf786acd6
DOI
10.1101/562744
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting endometrial cancer stem cell activity with metformin is inhibited by patient-derived adipocyte-secreted factorsDOI 10.1101/562744
Select a neighboring publication to make it the new centre.